Onyx Biotec IPO

Listed Listed stocks

Onyx Biotec IPO Details

  • Bidding Date

    13-Nov-2024 to
    18-Nov-2024

  • Issue Size

    ₹29.34 Cr

  • Price Band

    ₹58 to ₹61

  • Allotment date

    19-Nov-2024

  • Listing date

    22-Nov-2024

  • Lot size

    2000

  • No. of shares

    48,10,000

  • Fresh issue/OFS

    ₹29.34 Cr /--

About Onyx Biotec Company

Onyx Biotec is a pharmaceutical contract manufacturer specializing in sterile pharmaceutical products. The company started its operations in the pharmaceutical industry in 2010, initially with sterile water for injections. Over the years, Onyx expanded its product portfolio to include Dry Powder Injections and Dry Syrup for both domestic and international markets. Their core business is focused on providing end-to-end product development and manufacturing solutions, which includes the preparation and filing of regulatory dossiers for the Indian and global markets. The company supplies to major pharmaceutical companies across India and globally, including Hetero Healthcare, Mankind Pharma, Sun Pharmaceutical, Aristo Pharmaceuticals, and others. the company manufactures these products in two facilities in Himachal Pradesh, with modern equipment and sustainable practices in place.

Subscription Status

  • Category

    Status

  • QIBs

    --

  • NIIs

    --

  • Retail

    --

  • Others

    --

  • Total

    183.9x

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Clay Craft India 193 - 203 17-Jun-2026 to 19-Jun-2026
Diksha Polymers 112 17-Jun-2026 to 19-Jun-2026
Liotech 321 17-Jun-2026 to 19-Jun-2026
Leapfrog Engineering Services 21 - 23 17-Jun-2026 to 19-Jun-2026
IPO MonitorIPO Monitor

FAQs for Onyx Biotec IPO.

The issue size of Onyx Biotec is ₹29.34 Cr.

Onyx Biotec falls into Healthcare Devices & Equipment industry.

The Onyx Biotec IPO will be listed on BSE.

The open and close dates for the Onyx Biotec are 13-Nov-2024 & 18-Nov-2024.

The price band for the Onyx Biotec ipo is ₹58 to ₹61

The listing date of Onyx Biotec IPO is 22-Nov-2024.

The purpose of this IPO is to raise fresh capital.

Onyx Biotec total subscription ratio is 183.9X.

Key financial of the Onyx Biotec are:


Onyx Biotec FY-24 FY-23 FY-22
Revenue (₹ Cr) 53.75 39.48 44.86
EBIT (₹ Cr) 6.52 3 4.32
Proft after Tax (₹ Cr) 3.63 1.84 3.35
Debt (₹ Cr) 30.78 29.23 12.24
Net Worth (₹ Cr) 25.29 18.2 16.38
RoE (%) 14.37 10.13 20.47